Inventor
STOCKWELL BRENT R
US24 patents
⚠️ This page may combine multiple inventors who share the name “STOCKWELL BRENT R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV COLUMBIA
10 patentsUS9695133B2Jul 4, 2017
Quinazolinone-based oncogenic-RAS-selective lethal compounds and their use
UNIV COLUMBIA8 citations82
US9580398B2Feb 28, 2017
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
UNIV COLUMBIA8 citations81
US11192849B2Dec 7, 2021
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
UNIV COLUMBIA2 citations71
US10259775B2Apr 16, 2019
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
UNIV COLUMBIA2 citations71
US10597381B2Mar 24, 2020
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
UNIV COLUMBIA3 citations70
US10233171B2Mar 19, 2019
Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
UNIV COLUMBIA2 citations70
US10947188B2Mar 16, 2021
Small molecule ferroptosis inducers
UNIV COLUMBIA1 citations61
US12227500B2Feb 18, 2025
Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum stress
UNIV COLUMBIA0 citations53
US9926293B2Mar 27, 2018
Multivalent RAS binding compounds
UNIV COLUMBIA1 citations51
US9938245B2Apr 10, 2018
Carbonyl erastin analogs and their use
UNIV COLUMBIA1 citations48
COMBINATORX INC
4 patentsUS6569853B1May 27, 2003
Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
COMBINATORX INC111 citations98
US6693125B2Feb 17, 2004
Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
COMBINATORX INC117 citations97
US6846816B2Jan 25, 2005
Combinations of drugs for the treatment of neoplastic disorders
COMBINATORX INC26 citations92
US7148216B2Dec 12, 2006
Combinations of drugs for the treatment of neoplastic disorders
COMBINATORX INC9 citations73
STOCKWELL BRENT R
3 patentsUS8546421B1Oct 1, 2013
Oncogenic-RAS-signal dependent lethal compounds
STOCKWELL BRENT R5 citations65
US8535897B2Sep 17, 2013
Assays for non-apoptotic cell death and uses thereof
STOCKWELL BRENT R3 citations60
US8124365B2Feb 28, 2012
Identification of genotype-selective anti-tumor agents
STOCKWELL BRENT R0 citations50